The biosynthetic gene cluster for rebeccamycin, an indolocarbazole antibiotic, from Lechevalieria aerocolonigenes ATCC 39243 has 11 ORFs. To clarify their functions, mutants with rebG, rebD, rebC, rebP, rebM, rebR, rebH, rebT, or orfD2 disrupted were constructed, and the gene products were examined. rebP disruptants produced 11,11?-dichlorochromopyrrolic acid, found to be a biosynthetic intermediate by a bioconversion experiment. Other genes encoded N-glycosyltransferase (rebG ), monooxygenase (rebC ), methyltransferase (rebM ), a transcriptional activator (rebR), and halogenase (rebH ). rebT disruptants produced rebeccamycin as much as the wild strain, so rebT was probably not involved in rebeccamycin production. Biosynthetic genes of staurosporine, an another indolocarbazole antibiotic, were cloned from Streptomyces sp. TP-A0274. staO, staD, and staP were similar to rebO, rebD, and rebP, respectively, all of which are responsible for indolocarbazole biosynthesis, But a rebC homolog, encoding a putative enzyme oxidizing the C-7 site of pyrrole rings, was not found in the staurosporine biosynthetic gene cluster. These results suggest that indolocarbazole is constructed by oxidative decarboxylation of chromopyrrolic acid (11, 11 ?-dichlorochromopyrrolic acid in rebeccamycin) generated from two molecules of tryptophan by coupling and that the oxidation state at the C-7 position depends on the additional enzyme(s) encoded by the biosynthetic genes. Key words: rebeccamycin; indolocarbazole; biosynthetic pathway; Lechevarielia aerocolonigenes ATCC 39243; chromopyrrolic acid Rebeccamycin ( Fig. 1 ) is an indolocarbazole alkaloid produced by Lechevalieria aerocolonigenes ATCC 39243.* It inhibits DNA topoisomerase I with an IC50 of 1.75 mM in vitro and inhibits the growth of human lung adenocarcinoma cells with a GI50 of 6.0 mg W ml in vivo.
1) Indolocarbazole compounds from natural sources have attracted attention because of they are inhibitors of protein kinases or DNA topoisomerases. Staurosporine (Fig. 1) , the strongest inhibitor of phospholipid-Ca 2+ -dependent protein kinase (protein kinase C), with an IC50 of 2.7 nM, is frequently used to study cellular processes.
2) Protein kinases and DNA topoisomerases are important in cell proliferation, so speciˆc inhibitors are promising candidates for antitumor drugs. In fact, UCN-01, 3) BMY-27557, 4) and J-109384 5) are indolocarbazoles now in clinical trials for cancer chemotherapy.
Most indolocarbazole compounds are isolated from actinomycetes: rebeccamycin is from Lechevalieria aerocolonigenes ATCC 39243, staurosporine is from L. aerocolonigenes subsp. staurosporeus and Streptomyces sp. strain TP-A0274, K252a is from Nocardiopsis sp. strain K252 6) and J-104303 is from Streptomyces mobaraensis BA 13793. 7) Biosynthetic studies done with isotope-labeled precursors indicated that the indolocarbazole structure is derived from two molecules of tryptophan, probably via indolepyruvic acid as an intermediate. [8] [9] [10] Ohuchi et al. reported cloning of the ngt gene encoding an Nglycosyltransferase from L. aerocolonigenes ATCC 39243.
5) The Ngt protein converted an indolocarbazole, J-104303, to its N-glucoside, indicating that ngt is responsible for N-glycosylation in rebeccamycin biosynthesis. Very recently, in aˆrst report about indolocarbazole antibiotics, Sanchez et al. cloned the rebeccamycin biosynthetic genes, using an internal fragment of ngt as a probe. 11) Nucleotide sequence analysis of a 25.6-kb fragment of the L. aerocolonigenes ATCC 39243 genome found 18 open reading frames (ORFs). On the basis of sequence analysis and database searches, they proposed four genes for indolocarbazole biosynthesis (rebO, rebD, rebC, and rebP ), two genes for halogenation (rebH, and rebF ), glycosylation (rebG, the name was changed from ngt ), and sugar methylation (rebM ), as well as a regulatory gene (rebR) and two resistance and secretion genes (rebU and rebT ). Heterologous gene expression of the set rebO, rebD, rebC, and rebP for indolocarbazole biosynthesis resulted in production of deschlororebeccamycin aglycone. We have been independently investigating the biosynthetic genes for rebeccamycin, 12) and discovered its biosynthetic pathway with the identiˆcation of several key biosynthetic intermediates. We here characterize the biosynthetic gene cluster for rebeccamycin using a newly developed host-vector system for the genus Lechevalieria and gene-disruption experiments. The structures of the accumulated products of each reb disruptant were identiˆed and an overall biosynthetic pathway of rebeccamycin is proposed.
Materials and Methods
Bacterial strains, plasmids, and growth condition. L. aerocolonigenes ATCC 39243 was obtained from the American Type Culture Collection and used as the source of DNA in the construction of the genomic libraries. Streptomyces sp. strain TP-A0274 was newly isolated from soil collected in Kosugi-machi, Toyama, Japan. Escherichia coli DH-5a served as the host for plasmid subcloning in pUC19 and pK18mob.
13) E. coli XL1-Blue MR was used for cloning of the pK402 14) and the pTOYAMAcos cosmid (Onaka, in preparation) . E. coli S17-1 was used for transconjugation. 15) Growth conditions and manipulations of E. coli were as described by Sambrook and Russell.
16) The production medium for L. aerocolonigenes was medium G134. 1) The seed culture for L. aerocolonigenes was in V-22 medium. 17) Bennett's glucose agar, 17) nutrient broth agar, and mannitol soya ‰our agar 18) were used for conjugational transformation.
General recombinant DNA techniques. Restriction enzymes, T4 DNA ligase, and Taq polymerase were purchased from New England Biolabs. DNA fragments were labelled with [a-32 P]-dCTP (6000 Ci mmol "1 ; Amersham) and the BcaBEST labelling kit (Takara Shuzo Co., Ltd.). PCR was carried out with the PTC-200 DNA Engine (MJ Research, MA, USA). DNA manipulations were as described by Sambrook and Russell. 16) Cloning of the rebeccamycin biosynthetic genes. The two PCR primers, 5?-TCGGAATTCATGG-GGGCACGAGTGCTG-3? (NGT1) and 5?-AGGA-AGCTTGAACGGGCCGACGAACCT-3? (NGT2), were synthesized on the basis of the ngt DNA sequence recorded as accession No. AB023953 in GenBank. Underlining letters indicate EcoRI and HindIII restriction enzyme sites for cloning to vectors. A 731-bp DNA fragment was ampliˆed by PCR with each of the PCR primers and L. aerocolonigenes chromosomal DNA. The ampliˆed products were radiolabelled by the random priming method and put through colony hybridization. For the construction of a genomic library, chromosomal DNA of L. aerocolonigenes was prepared as described by Kieser et al. 18) and partially digested with Sau3AI, and DNA fragments of À30 kb were puriˆed by gel electrophoresis. The puriˆed DNA fragments were ligated with pKU402 and packaged into l phage. A hybridized cosmid, pREBC5, was digested with BamHI and the hybridizing 8-kb fragment was subcloned into pUC19 to give pREB1. 3.4-kb BamHI, 2.9-kb BamHI, 2.7-kb SphI, 2-kb Pst I, and 2.3-kb XhoI fragments, which were upstream from of the 8-kb fragment, also were cloned into pUC19 to give pREB5, pREB7, pREB9, pREB10, and pREB11, (see Fig. 2(A) ).
Construction of plasmids for gene inactivation. (i) pDrebG. pDrebG was constructed by the cloning of a 776-bp PmaCI-SphI fragment prepared from pREB1, which contained an internal region of the rebG gene, into the SmaI-SphI sites of pK18mob. (ii) pDrebD, pDrebP, pDrebM, pDrebH, pDrebT, and pDorfD2. A 543-bp fragment was ampliˆed by PCR with primers designed on the basis of the internal region of the rebD and pREB1 as the template. The fragment was inserted into pK18mob to give pDrebD. Five plasmids, pDrebP, pDrebM, pDrebH, pDrebT, and pDorfD2, which contained internal regions of rebP, rebM, rebH, rebT, and orfD2 as shown in Fig. 2(A) , also were constructed by the (iii) pDrebC and pDrebR. For in-frame deletion of the rebC, a 3.0-kb SphI fragment was prepared from pREB1 and cloned into the SphI site of pUC19 to generate pREB1A. The plasmid was digested with NcoI and the resulting rebC-truncated large fragment was puriˆed and self-ligated to give pREB1B. A 2.9-kb BamHI-EcoRI fragment was prepared from pREB5 and subcloned into the BamHI-EcoRI site of pREB1B to construct pREB1C. A 5-kb EcoRI-HindIII fragment was prepared from pREB1C and cloned into the EcoRI-HindIII site of pK18mob to construct pDrebC. For in-frame deletion of rebR, a 2.2-kb SphI fragment was prepared from pREB7 and cloned into the SphI site of pK18mob to generate pREB7A. A 2.3-kb Pst I fragment (one of the Pst I sites is on a multiple cloning site of pUC19) was prepared from pREB5 and subcloned into the Pst I site of pREB7A to construct pDrebR. Both of the deletion regions are shown in Fig. 2 
(A).
Gene disruption and transformation in Lechevalieria aerocolonigenes. For disruption of the chromosomal genes, we used the method of insertional inactivation via a single crossover with the nonreplicating E. coli plasmid, pK18mob, derivatives (pDrebG, pDrebD, pDrebP, pDrebM, pDrebH, pDrebT, and pDorfD2) or via a double crossover with pDrebC and pDrebR. rebG and rebC double disruptants were constructed from the rebC-truncated mutant strain to use the method via a single crossover with pDrebG. The method of transconjugation is modiˆed from the method for Streptomyces species as described by Mazodier et al. 15) After transconjugation, 3 ml of 0.5z nutrient broth agar (Difco) with 200 mg W ml kanamycin was overlaid on a mannitol soya ‰our agar plate for transformant selection and the selected colonies were transferred to a Bennett's glucose agar plate containing 5 mg W ml nalidixic acid and 20 mg W ml kanamycin. The chromosomal DNAs were prepared from the candidate transformants and the restriction map of the chromosomal DNA was checked by Southern hybridization. For disruption of the chromosomal genes with pDrebC and pDrebR,ˆrst crossover events were done with the same method as for single crossover disruption. The pDrebC-or pDrebR-integrated strains were cultivated in a 500-ml K-1 ‰ask containing 100 ml of V-22 medium with no antibiotics. After two rounds of cultivation, we selected colonies that were kanamycin-sensitive to obtain in-frame deletion mutants. The genomic structure of the strains obtained was checked by Southern hybridization.
HPLC of the products from gene-disrupted mutants. HPLC was done on a HP1090 system with a diode array detector (Hewlett Packard) and a C18 Rainin Microsorb column (3 mm, 100×4.6 mm, i.d.; Rainin Instrument Co., MA, USA). Acetonitrile-0.15z KH2PO4 was the elution buŠer. The temperature was 409 C, the ‰ow rate was 1.2 ml W min, the solvent was acetonitrile-0.15z KH 2 PO 4 (pH 3.5), and detection was at 254 nm. (the gradient diagram is in Fig. 4(A) ) Each of the disrupted mutants was used to inoculate a 500-ml K-1 ‰ask containing 100 ml of V-22 medium. After incubation at 309 C for 2 days on a rotary shaker at 200 rpm, 5-ml portions of the seed culture were transferred into 500-ml K-1 ‰asks containing 100 ml of medium G134. Fermentation was at 309 C for 11 days on the same rotary shaker. The culture broth was centrifuged to collect a mycelial cake, which was extracted with 100 ml of acetone. After the acetone was evaporated oŠ, the resultant solution was extracted with 100 ml of ethyl acetate three times, concentrated under reduced pressure, and dissolved in Me2SO for HPLC. The supernatant of the culture broth also was checked for production of rebeccamycin or its related compounds.
Puriˆcation of rebeccamycin intermediates.
To purify the rebeccamycin aglycon (5), L. aerocolonigenes rebG ::km r was used to inoculate 500-ml K-1 ‰asks containing 100 ml of V-22 medium. After cultivation at 309 C for 2 days on a rotary shaker, 5-ml portions of the seed culture were transferred intoˆfty 500-ml K-1 ‰asks, each containing 100 ml of medium G134. The culture broth (5 liters) was centrifuged at 5000×g for 10 min. The supernatant was discarded and the mycelial cake was extracted with 5 liters of acetone. After the evaporation, the resultant aqueous solution was extracted with an equal volume of ethyl acetate two times and concentrated under reduced pressure to give 1.2 g of crude extract. The residue was dissolved in 2.5 ml of methanol and put on an ODS-AM reverse-phase silica gel column (4.6 i.d.×20 cm; YMC) equilibrated with 20z aqueous methanol. The column was eluted with 50z aqueous methanol and then 100z methanol. The rebeccamycin aglycon eluted in the 100z methanol fraction. The fractions containing the rebeccamycin aglycon were pooled, and evaporated under reduced pressure to give pure rebeccamycin aglycon (61.2 mg). For puriˆcation of 4 (11,11?-dichlorochromopyrrolic acid), 10 (4?-O-demethylrebeccamycin), 8 (7-deoxo-7-hydroxyrebeccamycin aglycon), 9 (7-deoxorebeccamycin aglycon), and 11 (1,11-dechloro-4?-O-demethylrebeccamycin), strain rebD::km r (4), strain rebM ::km r (10), strain DrebC+rebG ::km r (8, 9), or strain rebH ::km r (11) was used and the puriˆcation method was the same as for rebeccamycin aglycon except that the materials eluted in the 50z methanol fraction from the ODS-AM column. Further HPLC was done of the products from strain DrebC+rebG ::km r (8, 9) and strain rebH ::km r (11) to obtain purity high enough for NMR. HPLC puriˆcation was done on a Shimadzu HPLC system (SPD-M10A) with a diode array detector (LC10-AT, Shimadzu) and an XTerra RP18 column (19 i.d.×300 mm; Waters). Partially puriˆed samples containing the intermediates were dissolved in methanol and put on an HPLC column. The temperature was 309 C, ‰ow rate 15 ml W min, solvent 50z acetonitrile-0.15z KH2PO4 (pH 3.5). Each intermediate was fractionated on the basis of the information from the diode array detector, with detection at 254 nm.
Analysis of metabolites.
1 H and 13 C NMR spectra were measured at 400 and 100 MHz in Me2SO-d6 on a JNM-LA400 apparatus (JEOL). LC-MS spectra were obtained on an API165 machine (Applied Biosystems). UV-visible spectra were taken on a HP1090 system. NMR data for compounds 4, 5, 8, 9, 10, and 11 are shown in Tables 1 to 3 Bioconversion experiments. Two hundred mg of a putative puriˆed intermediate was added to a tube containing 10 ml of medium G134 and already cultured L. aerocolonigenes rebH ::km r was used to inoculate the same tube. After cultivation at 309 C for 5 days and 7 days on a rotary shaker, 5-ml portions were extracted. HPLC conditions and sample preparation were as described in the section on HPLC of the products from gene-disrupted mutants. The rebeccamycin production was identiˆed with the reten-tion time by HPLC and from the UV-visible spectrum.
Cloning and sequencing of the staurosporine biosynthetic genes. The staD gene fragment was ampliˆed from Streptomyces sp. strain TP-A0274 genomic DNA with the primers rebBN and rebBC, designed on the basis of the rebD and vioB sequence, and was used as a colony hybridization probe. The sequences of primers were (rebBN)
For the construction of a genomic library, chromosomal DNA of Streptomyces sp. strain TP-A0274 was partially digested with Sau3AI, and DNA fragments of À30 kb were puriˆed by gel electrophoresis. The resulting DNA fragments were ligated with BamHI-digested pTOYAMAcos, which is an actinomycetes-E. coli shuttle cosmid vector, and packaged into l phage. Five hybridized cosmids were isolated. A selected cosmid was designated pTYMCsta and digested with BamHI, and the hybridizing 5.6-kb fragment was subcloned into pUC19 to give pSTA1. Two-kilobase and 2.3-kb BamHI fragments, which were in the upstream and downstream regions of the 5.6-kb fragment, respectively, also were cloned into pUC19 to give pSTA2 and pSTA3, as shown in Fig. 2(B) . These fragments were sequenced with an ABI PRISM cycle sequencing kit and analyzed on a ABI PRISM 310 automated sequencer (Applied Biosystems). The templates for DNA sequencing were prepared with the Locus Pocus transposon insertion system kit (Novagen). The DNA and protein sequence similarity searches were done with the BLAST server at the National Center for Biotechnology Information (Bethesda, MD).
Nucleotide sequence accession number. The nucleotide sequence for the rebeccamycin biosynthetic genes has been deposited in the DDBJ database under DDBJ Accession Number AB071405 and that for the staurosporine biosynthetic genes has been deposited under DDBJ Accession Number AB071406.
Results and Discussion

Construction of disrupted mutants for biosynthesis
The conventional transformation protocol involving protoplasting and regeneration of mycelia usually used for Streptomyces strains could not be used for L. aerocolonigenes ATCC 39243. We therefore developed a protocol for conjugational transfer from E. coli to strain ATCC 39243 by modifying the Streptomyces method. 15) A plasmid, pK18mob, carrying the ColE1 replicon and an origin essential for conjugal transfer was used. Chromosomal DNAs were prepared from transformants that grew well on the selection plates, and chromosomal recombination events was monitored by Southern hybridization (Figs. 3(C) and 3(D) ). Except for rebC and rebR disruptants, insertional inactivation via a single crossover was conˆrmed (Fig. 3(A) ). rebC and rebR were disrupted by in-frame deletion (Fig. 3(B) ) because insertional inactivation of rebC or rebR probably would have a polar eŠect on the transcription of genes downstream form rebC or rebR (Fig. 2(A) ). Double disruptants of rebC and rebG were constructed from an in-frame rebC deletion mutant by a single crossover in the rebG region. Finally, three mutants were independently isolated and further analyzed for each of the following: rebG, rebD, rebC, rebC+rebG, rebP, rebR, rebH, rebT, and orfD2 disruptants. Two mutants were isolated from rebM disruptants and analyzed.
Characterization of rebeccamycin biosynthetic genes
The rebG, rebD, rebC, rebP, rebM, rebR, and rebH genes were conˆrmed to constitute the rebeccamycin biosynthetic gene cluster by gene disruption experiments. Although the cloning and expression of rebG was previously described, 5) it was not proved there that rebG is involved in rebeccamycin biosynthesis. We constructed a rebG mutant by gene disruption and found that it produced the rebeccamycin aglycon but not rebeccamycin (Fig. 4(B) ). The rebG product therefore was the N-glycosyltransferase responsible for rebeccamycin biosynthesis.
rebD encoded a protein of 1,013 amino acid residue. A BLAST search indicated 36.6z identity over the entire sequence of RebD to VioB, which is involved in violacein (Fig. 1 ) biosynthesis in Chromobacterium violaceum and catalyzes a condensation reaction of 5-hydroxytryptophan and indolepyruvic acid to generate the bisindole intermediate for violacein. 19) The rebD-disrupted mutant did not produce compounds related to indolocarbazoles (Fig. 4(C) ); in the same way, the vioB disruptant does not produce any violacein related metabolites. 19) rebO, rebD, rebC, and rebP seemed to be translationally coupled, suggesting that at least these four genes might be transcribed polycistronically. Strain rebD::km r might have polar eŠects on the expression of rebC and rebP, but we could ignore such eŠects in this experiment because rebC and rebP products were involved in later biosynthetic steps than the rebD product, as described in the following paragraph (A) Schematic presentation of rebG gene disruption via single crossover. The 0.78-kb PmaCI-SphI DNA fragment used as the probe is indicated as a thin black bar. X, XhoI; km r , kanamycin resistance gene (aphII ). rebD, rebP, rebC+rebG, rebM, rebH, rebT, and orfD2 disruptants were prepared by a similar procedure. (B) Schematic presentation of rebC gene disruption with an in-frame deletion. N, NcoI. (C) Southern blotting of L. aerocolonigenes wild type (W) and a disruptant of rebG, rebD, rebP, rebC+rebG, rebM, rebH, rebT, or orfD2. The chromosomal DNAs were digested with XhoI (rebG and rebH ), Sal I (rebC+rebG and rebD), BamHI (orfD2, rebP, rebT, and rebM ). The 0.78-kb internal rebG fragment from pDrebG, 0.54-kb rebD fragment from pDrebD, 0.61-kb rebP fragment from pDrebP, 0.42-kb rebM fragment from pDrebM, 0.42-kb rebH fragment from pDrebH, 0.92-kb rebT fragment from pDrebT, and 0.57-kb orfD2 fragment from pDorfD2 were used as 32 P-labelled probes. (D) Southern blotting of a disruptant of rebC or rebR. The chromosomal DNAs were digested with SacI (rebC ) and PvuII (rebR). The 0.54-kb rebD fragment from pDrebD and 2.2-kb SphI fragment from pREB7 were used as rebC and rebR probes, respectively. Lanes 1 and 2 indicate pDrebC-and pDrebR-integrated strains.
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about results of the analysis of rebP and rebC disruptants. Considering the structural similarities of violacein and rebeccamycin, both of which are derived from two molecules of tryptophan, this observation led us to propose that RebD is involved in the construction of the bisindole structure by catalyzing a coupling reaction between 7-chlorotryptophan and 7-chloroindole-3-pyruvic acid.
The rebP gene product is quite similar to a cytochrome-P-450-like enzyme. The major product that the rebP disruptant accumulated was 11,11?-dichlorochromopyrrolic acid (CCA, 4) (Fig. 4(D) ). The structure of CCA was identiˆed from NMR and MS spectra. A 13 C NMR spectrum showed 11 sp 2 carbons, suggesting that CCA was a symmetrical molecule and that all of the carbons in tryptophan were retained in CCA.
1 H-13 C long-range couplings observed in the HMBC spectrum conˆrmed the chloroindole moiety (Fig. 5(A) ). The presence of a pyrrole ring was not directly conˆrmed by HMBC, but the structure of CCA was deduced to be the chlorinated analog of chromopyrrolic acid 20) by the LC-MS, which gave a molecular ion [M+H] + at m W z 454.2, and by comparison of NMR results with those reported for chromopyrrolic acid. Chromopyrrolic acid [3,4- 
is a secondary metabolite found in C. violaceum, a producer of violacein. 20) The close similarity of vioB and rebD suggested that CCA was biosynthesized directly by RebD. Conversion of CCA to indolocarba- HPLC conditions and sample preparation were described in the text. The elution was done with a linear gradient as indicated on the right-hand scale in A.
zole through oxidative decarboxylation is generally thought to be catalyzed by RebP. In a check of our proposal, a bioconversion experiment was done (Fig. 6) . CCA was added to the culture broth of the rebH disruptant and the products were analyzed by HPLC after 5 and 7 days. The peak of CCA (9.9 min) disappeared and the production of rebeccamycin (13.3 min) was detected after 7 days (Fig. 6(B) ). Because the rebH disruptant was unable to produce chlorinated indolocarbazoles, including rebeccamycin, we concluded that CCA was converted to rebeccamycin as a biosynthetic intermediate.
The rebC gene product was similar to a ‰avin binding site containing monooxygenase. The rebC-trun- The Me2SO4-d6 signal (2.49 ppm) was used as a reference. Integral multiplicities, and coupling constants (Hz) are in parentheses. The Me2SO-d6 signal (39.5 ppm) was used as a reference. * and ** , interchangeable. cated mutant produced several indolocarbazole products (Fig. 4(E) ). The UV-visible spectrum showed that products 6 and 7 contained the indolocarbazole chromophore. This result indicates that indolocarbazole could be constructed without the involvement of the rebC product. The compounds of 6 and 7 were found to be 7-deoxo-7-hydroxyrebeccamycin and its 4?-O-demethyl derivative, on the basis of the following observations: in LC-MS, the peaks at 7.7 (6) and 9 (7) min showed the molecular ion [M+H] + at m W z 572 and 558, two units higher than that of rebeccamycin (m W z 570) and 4?-O-demethylrebeccamycin (m W z 556), respectively; NMR results showed that each peak consisted of a mixture of 12-N-and 13-N-glycosides not separable on HPLC (NMR results not shown). Taken together, with the function of RebC assumed from the sequence similarity, the structures of 6 and 7 were deduced to be 7-deoxo-7-hydroxyrebeccamycin and its 4?-O-demethyl derivative, although it is not clear whether the glycosylation site was at the 12-or 13-nitrogen. The rebG disruption experiment showed that N-glycosylation happened after indolocarbazole formation. We concluded that these two glycosylated products are shunt products. We then constructed rebG and rebC double disruptants to eliminate the glycosylated products, and analyzed the fermented products. Three peaks were detected in HPLC of the culture broth (Fig. 4(F) , peaks 5, 8, and 9), and they were identiˆed as rebeccamycin aglycon (5), 7-deoxo-7-hydroxyrebeccamycin aglycon (8) , and 7-deoxorebeccamycin aglycon (9) , respectively, by NMR. NMR assignments and HMBC results for 5, 8, and 9 are summarized in Tables 1 and 2 NMR results for these compounds showed similarity to reported values. 21, 22) Bioconversion experiments with 8 or 9 as an added sample were done to conˆrm which was the real intermediate, but neither compound was converted to rebeccamycin. Presumably, in the rebC disruptants, the other oxidase enzymes recognize the real intermediate of rebC disruptants as a substrate and produce 8 and 9. The RebC products were not conˆrmed in these disruption experiments, although, considering that rebeccamycin aglycon was identiˆed as one of the products, we suppose that RebP took part in the conversion from CCA to rebeccamycin aglycone and that RebC controlled the oxidation state at the C-7 site.
The rebM product was similar to methyltransferases from various organisms. The rebM disruptant accumulated compound 10 ( Fig. 4(G) ), which was identiˆed as 4?-O-demethylrebeccamycin 23) by NMR (Tables 1 and 2 and Fig. 5(E) ) and LC-MS, which gave a [M+H] + ion at m W z 556.0. Therefore, rebM encoded the methyltransferase responsible for methylation at the 4-hydroxy group of the glucose moiety. Additionally, 4?-O-demethylrebeccamycin was converted to rebeccamycin by an rebH disruptant (not shown), which conˆrmed that the methylation was the last step of the biosynthesis.
The rebH gene product was similar to the tryptophan halogenase from Pseudomonas chlororaphis, which enzyme catalyzes the chlorination reaction from L-tryptophan to 7-chloro-L-tryptophan in pyrrolnitrin biosynthesis. 24) The rebH disruptant produced an indolocarbazole compound, 11, corresponding to the peak at 7.9 min on HPLC (Fig. 4(H) ). The mass spectrum showed [M+H] + at m W z 487 and NMR conˆrmed compound 11 to be 1,11-dechloro-4?-O-demethylrebeccamycin. The NMR results for 11 were in accordance with those reported earlier. 11) We concluded that RebH is responsible for chlorination of the indole moiety. Taking into account the similarity to the tryptophan halogenase from P. chlororaphis, chlorination probably takes place with tryptophan at the beginning of the biosynthetic cascade. The production of 1,11-dechloro-4?-O-demethylrebeccamycin might be allowed by substrate recognition by RebO, RebD, RebC, RebP, and RebG.
Regulatory and other genes A database search found that RebR was similar to an luxR family transcriptional regulator. In our experiment, the rebR-truncated mutant did not produce compounds related to rebeccamycin (Fig. 4(I) ). Sanchez et al. reported that rebR is essential for production in the heterologous expression of indolocarbazole biosynthesis genes. 11) Theseˆndings indicate that RebR is a pathway-speciˆc activator for rebeccamycin production.
rebT was at the end of the rebeccamycin biosynthetic gene cluster and was similar to transmembrane eOEux proteins, which are candidates for rebeccamycin resistance or secretion. Disruption of rebT did not decrease the production level: the wild type produced rebeccamycin at the concentration of 52.5±7 mg W l in 9 days of culture, and the rebT disruptants produced it at the concentration of 52.6±1 mg W l. Sanchez et al. reported that rebT introduced into Streptomyces albus confers resistance to rebeccamycin. 11) RebT might protect cells from the in‰ux of an excess of rebeccamycin. We concluded that rebT is not involved in the rebeccamycin production in L. aerocolonigenes ATCC 39243.
orfD2 was immediately downstream of rebG with the reverse orientation on the chromosomal DNA. The orfD2-disrupted mutants produced as much rebeccamycin as the wild type strain did (Fig. 4(J) ), indicating that orfD2 was not related to rebeccamycin biosynthesis and that the rebG gene was at the end of the rebeccamycin biosynthetic cluster.
Similarities and diŠerences in indolocarbazole biosynthetic genes between rebeccamycin and staurosporine
The staurosporine-producing strain Streptomyces sp. strain TP-A0274 was newly isolated from a soil sample collected in Toyama, Japan, and the staurosporine biosynthetic gene cluster was cloned on the basis of information from the rebD nucleotide sequence. The genomic library of strain TP-A0274 was constructed and the biosynthesis gene was screened for with colony hybridization. The selected cosmid, pTYMCsta, was conˆrmed to include the entire staurosporine biosynthetic genes by heterologous expression in Streptomyces lividans TK23. 25) The gene organization map of rebD homolog loci is shown in Fig. 2(B) . A comparison between the amino acid sequences encoded by staG and rebG from L. aerocolonigenes found 55.8z identity, suggesting that staG encoded an N-glycosyltransferase. Upstream from staG, there were three ORFs, staO, staD, and staP, and the deduced amino acid sequences were similar to rebO (53.2z identity, 80.3z similarity), rebD (55.2z identity, 77.4z similarity), and rebP (51.8z identity, 79.8z similarity), respectively, suggesting that these ORFs encoded indolocarbazole biosynthesis genes. There was no gene similar to rebC in the staurosporine biosynthetic genes in strain TP-A0274. The diŠerences in the structures of staurosporine and rebeccamycin aglycon were the presence or absence of a carbonyl group at C-7. rebC-disrupted mutants produced 7-deoxo-rebeccamycin, so RebC seemed to catalyze the oxidation at the C-7-position to the carbonyl group.
Proposed overall biosynthetic pathway of rebeccamycin
The most strikingˆnding in this study was the identiˆcation of CCA as a biosynthetic intermediate: decarboxylation occurs after the coupling of two tryptophan-molecules derivative. On the basis of our results, the biosynthetic pathway for rebeccamycin shown in Fig. 7 is proposed. The initial step is the chlorination of tryptophan by the putative halogenase RebH. The produced 7-chlorotryptophan (13) is oxidatively deaminated by RebO to give 7-chloroindole-3-pyruvic acid (14) . The rebO gene product has 25.3z identity in its 473 amino acid sequence to the L-amino acid oxidase from Crotalus adamanteus (eastern diamondback rattlesnake), 26) which is a component of snake poison and catalyzes an oxidization reaction of L-tryptophan to indole-3-pyruvic acid. Therefore RebO may be responsible for the deamination of 7-chlorotryptophan. 7-Chloroindole-3-pyruvic acid (14) is then used in the coupling reaction with 7-chlorotryptophan catalyzed by RebD to aŠord CCA (4). This dicarboxylic bisindole compound 4 is transformed to the rebeccamycin aglycon (5) via a putative oxidative reaction catalyzed by RebP, and oxidation at the 7-position to the carbonyl by RebC follows. Finally, the rebeccamycin aglycon is glycosylated with D-glucose by RebG (10) , and the methylation of the hydroxyl group of the glucose moiety by RebM ends the biosynthesis of rebeccamycin.
Compared with the rebeccamycin biosynthetic pathway, staurosporin biosynthesis in strain TP-A0274 is proposed to be as follows. Tryptophan would be oxidatively deaminated by StaO to 3-indole pyruvic acid, and it would be used for the coupling reaction with tryptophan catalyzed by StaD to produce chromopyrrolic acid. As the last step of the aglycon biosynthesis, StaP would convert chromopyrrolic acid to staurosporine aglycon.
